Re: So many questions...
|
6
|
Resverlogix Corp.
|
Dec 07, 2019 06:02PM
|
Re: Is Resverlogix Legit?
|
6
|
Resverlogix Corp.
|
Jul 28, 2019 08:36AM
|
BETonMACE succeeds.....now what?
|
6
|
Resverlogix Corp.
|
May 29, 2019 09:39AM
|
What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
6
|
Zenith Epigenetics
|
Jul 20, 2019 08:39AM
|
Re: 3 ASN Kidney Conference Presentations Nov 8-9
|
6
|
Resverlogix Corp.
|
Nov 09, 2019 04:54PM
|
Bloom Burton & Co Healthcare Conference
|
6
|
Resverlogix Corp.
|
Apr 19, 2018 12:44PM
|
Re: NR: Resverlogix Highlights Key Accomplishments and 2018 Targets...
|
6
|
Resverlogix Corp.
|
Feb 08, 2018 08:54AM
|
Re: So is it RVX or the CRO,...
|
6
|
Resverlogix Corp.
|
Sep 04, 2019 09:38AM
|
BIO Investor Forum, Oct 22-23
|
6
|
Resverlogix Corp.
|
Oct 17, 2019 02:37PM
|
Re: Showcase Presentations
|
6
|
Resverlogix Corp.
|
Jan 16, 2017 10:50PM
|
Re: Presentation
|
6
|
Resverlogix Corp.
|
Jun 20, 2017 10:49AM
|
Welcome to the party ABBV-744
|
6
|
Resverlogix Corp.
|
Feb 22, 2018 10:52AM
|
Re: What Are Our Reasonable Expectations?.
|
6
|
Resverlogix Corp.
|
Feb 08, 2016 11:46AM
|
Re: Cleveland Clinic-Consult QD
|
6
|
Resverlogix Corp.
|
Apr 30, 2019 10:40AM
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
6
|
Zenith Epigenetics
|
Mar 07, 2017 11:12PM
|
Blinded Sub Group Data; post by Aureus on IV
|
6
|
Resverlogix Corp.
|
Oct 04, 2018 12:12PM
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
6
|
Resverlogix Corp.
|
Dec 05, 2017 02:22PM
|
Re: RVX ANNOUNCES LEAD DRUG APABETALONE PUBLICATION AND BIO 2016 PRESENTATION
|
6
|
Resverlogix Corp.
|
Jun 02, 2016 03:11PM
|
Re: Vacepa new
|
6
|
Resverlogix Corp.
|
Mar 19, 2019 05:58PM
|
Re: Preview Part II....
|
6
|
Resverlogix Corp.
|
Mar 31, 2017 07:36AM
|